{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:22:50Z","timestamp":1794446570032,"version":"4.9.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141203"],"award-info":[{"award-number":["82141203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22273023"],"award-info":[{"award-number":["22273023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3503400"],"award-info":[{"award-number":["2023YFC3503400"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijbiomac.2024.138529","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:10:21Z","timestamp":1733569821000},"page":"138529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring bifunctional molecules for anti-SARS-CoV-2 and anti-inflammatory activity through structure-based virtual screening, SAR investigation, and biological evaluation"],"prefix":"10.1016","volume":"287","author":[{"given":"Jiani","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.138529_bb0005","author":"WHO"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41467-023-36561-6","article-title":"Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies","volume":"14","author":"Planas","year":"2023","journal-title":"Nat. Commun."},{"issue":"7906","key":"10.1016\/j.ijbiomac.2024.138529_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"issue":"7898","key":"10.1016\/j.ijbiomac.2024.138529_bb0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"7923","key":"10.1016\/j.ijbiomac.2024.138529_bb0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cytogfr.2021.10.007","article-title":"Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism","volume":"63","author":"Ahmad","year":"2022","journal-title":"Cytokine Growth F. R."},{"issue":"578","key":"10.1016\/j.ijbiomac.2024.138529_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe8146","article-title":"Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys","volume":"13","author":"Speranza","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41467-022-28315-7","article-title":"Myeloid cell interferon responses correlate with clearance of SARS-CoV-2","volume":"13","author":"Singh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2021.03.002","article-title":"COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?","volume":"232","author":"Ombrello","year":"2021","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138529_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28751","article-title":"The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection","volume":"95","author":"Qudus","year":"2023","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138529_bb0055","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/jac\/dkac144","article-title":"Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation","volume":"77","author":"Padilla","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe4724","article-title":"JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality","volume":"7","author":"Stebbing","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138529_bb0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.138529_bb0070","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","article-title":"Nitric oxide signaling in health and disease","volume":"185","author":"Lundberg","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138529_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2024.138529_bb0090","article-title":"Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity","volume":"257","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijbiomac.2021.04.129","article-title":"Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro)","volume":"183","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105841","article-title":"Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection","volume":"224","author":"Li","year":"2024","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138529_bb0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/10286020.2011.554828","article-title":"Synthesis and biological evaluation of bilobol and adipostatin a","volume":"13","author":"Tanaka","year":"2011","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"25","key":"10.1016\/j.ijbiomac.2024.138529_bb0110","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.tetlet.2009.04.023","article-title":"Synthesis of resveratrol, DMU-212 and analogues through a novel Wittig-type olefination promoted by nickel nanoparticles","volume":"50","author":"Alonso","year":"2009","journal-title":"Tetrahedron Lett."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138529_bb0115","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.bmcl.2013.01.074","article-title":"Efficient synthesis of anacardic acid analogues and their antibacterial activities","volume":"23","author":"Mamidyala","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.138529_bb0120","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ejmech.2006.03.024","article-title":"Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication","volume":"41","author":"Li","year":"2006","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.138529_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141092","article-title":"Synthesis and biological evaluation of novel gigantol derivatives as potential agents in prevention of diabetic cataract","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.138529_bb0130","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.bmc.2004.08.008","article-title":"Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure\u2013activity relationship","volume":"12","author":"Murias","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr. Purif."},{"issue":"7811","key":"10.1016\/j.ijbiomac.2024.138529_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0145","unstructured":"Schr\u00f6dinger Release 2023-2: Protein Preparation Wizard."},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0150","series-title":"LLC, New York, NY","author":"Epik","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0155","series-title":"LLC, New York, NY","author":"Prime","year":"2023"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138529_bb0160","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsinfecdis.0c00815","article-title":"Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19","volume":"7","author":"Steuten","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138529_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138529_bb0170","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.138529_bb0175","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138529_bb0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","article-title":"Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening","volume":"3","author":"Zhu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138529_bb0190","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1021\/acs.jcim.0c00546","article-title":"Structure-based virtual screening to discover potential Lead molecules for the SARS-CoV-2 Main protease","volume":"60","author":"Gahlawat","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.138529_bb0195","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of Coronavirus Disease-19 (COVID-19) through computational drug repurposing study","volume":"60","author":"Wang","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0200","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138529_bb0205","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3109\/13880209.2013.792849","article-title":"Polydatin: a review of pharmacology and pharmacokinetics","volume":"51","author":"Du","year":"2013","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138529_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/ph16020190","article-title":"Discovery of polyphenolic natural products as SARS-CoV-2 Mpro inhibitors for COVID-19","volume":"16","author":"Kr\u00fcger","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.138529_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144212","article-title":"Oxyresveratrol: sources, productions, biological activities, pharmacokinetics, and delivery systems","volume":"26","author":"Likhitwitayawuid","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138529_bb0225","article-title":"Natural sources and pharmacological properties of pinosylvin","volume":"11","author":"Bakrim","year":"2022","journal-title":"Plants (Basel, Switzerland)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.138529_bb0230","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.taap.2012.05.023","article-title":"Resveratrol analogue 3,4,4\u2032,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells","volume":"263","author":"Piotrowska","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.138529_bb0240","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.3390\/molecules27227728","article-title":"Covalent warheads targeting cysteine residue: the promising approach in drug development","volume":"27","author":"Huang","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.138529_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103799","article-title":"The expanding repertoire of covalent warheads for drug discovery","volume":"28","author":"Mehta","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0250","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1038\/s41467-021-23751-3","article-title":"Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease","volume":"12","author":"Su","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0255","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","article-title":"Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2","volume":"14","author":"Sanders","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0260","series-title":"Gaussian, Inc., Wallingford CT","author":"Gaussian 16, Revision C.01","year":"2019"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.138529_bb0265","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.138529_bb0270","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acs.jctc.7b00788","article-title":"Libreta: computerized optimization and code synthesis for electron repulsion integral evaluation","volume":"14","author":"Zhang","year":"2018","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0275","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL M(pro) active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138529_bb0280","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41565-020-0752-z","article-title":"Dexamethasone nanomedicines for COVID-19","volume":"15","author":"Lammers","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.138529_bb0285","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1016\/j.apsb.2022.07.017","article-title":"Schaftoside inhibits 3CL(pro) and PL(pro) of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19","volume":"12","author":"Yi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720018","article-title":"Ugonin J acts as a SARS-CoV-2 3C-like protease inhibitor and exhibits anti-inflammatory properties","volume":"12","author":"Chiou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.138529_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113623","article-title":"Antiviral and anti-inflammatory activities of fluoxetine in a SARS-CoV-2 infection mouse model","volume":"23","author":"P\u00e9ricat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.138529_bb0300","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153704","article-title":"Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis","volume":"91","author":"Xiao","year":"2021","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.138529_bb0310","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/ptr.5363","article-title":"Preclinical pharmacokinetics and pharmacodynamics and content analysis of gnetol in foodstuffs","volume":"29","author":"Remsberg","year":"2015","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.138529_bb0315","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1271\/bbb.67.663","article-title":"Gnetol as a potent tyrosinase inhibitor from genus Gnetum","volume":"67","author":"Ohguchi","year":"2003","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.138529_bb0320","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.fitote.2012.03.009","article-title":"Potent and selective butyrylcholinesterase inhibitors from Ficus foveolata","volume":"83","author":"Sermboonpaisarn","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ijbiomac.2024.138529_bb0325","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3389\/fphar.2019.01613","article-title":"Protective effect of piceatannol against acute lung injury through protecting the integrity of air-blood barrier and modulating the TLR4\/NF-\u03baB signaling pathway activation","volume":"10","author":"Peng","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024093401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024093401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:07:53Z","timestamp":1782871673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024093401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":64,"alternative-id":["S0141813024093401"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138529","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring bifunctional molecules for anti-SARS-CoV-2 and anti-inflammatory activity through structure-based virtual screening, SAR investigation, and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138529"}}